Provided by Tiger Trade Technology Pte. Ltd.

Pliant Therapeutics, Inc.

1.14
-0.0150-1.30%
Post-market: 1.12-0.0197-1.73%17:53 EDT
Volume:316.09K
Turnover:359.30K
Market Cap:70.58M
PE:-0.76
High:1.15
Open:1.14
Low:1.12
Close:1.16
52wk High:1.95
52wk Low:1.02
Shares:61.91M
Float Shares:55.03M
Volume Ratio:0.44
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5000
EPS(LYR):-2.4336
ROE:-50.29%
ROA:-23.27%
PB:0.48
PE(LYR):-0.47

Loading ...

May 05, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K/A [Amend] - Current report
Mar 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2021

Major Issues Report

8-K - Current report
Sep 07, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 02, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Mar 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]